Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Cipla
Express Scripts
Fuji
AstraZeneca
Fish and Richardson
Chubb
Johnson and Johnson
QuintilesIMS

Generated: September 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,648,333

« Back to Dashboard

Summary for Patent: 5,648,333
Title: Peptides having bradykinin antagonist action
Abstract:Peptides of the formula I wherein the terms A, B, C, E, F, K, P, G, M, F', and I are defined in the specification, have bradykinin antagonist action. Their therapeutic utility includes all pathological states which are mediated, caused or supported by bradykinin and bradykinin-related peptides.
Inventor(s): Henke; Stephan (Hofheim am Taunus, DE), Anagnostopulos; Hiristo (Wiesbaden, DE), Breipohl; Gerhard (Frankfurt am Main, DE), Knolle; Jochen (Kriftel, DE), Stechl; Jens (Frankfurt am Main, DE), Scholkens; Bernward (Kelkeim/Taunus, DE), Fehlhaber; Hans-Wolfram (Idstein, DE), Gerhards; Hermann (Hofheim am Taunus, DE), Hock; Franz (Dieburg, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Application Number:08/487,442
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,648,333
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 5,648,333

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Shire Orphan Therap FIRAZYR icatibant acetate INJECTABLE;SUBCUTANEOUS 022150-001 Aug 25, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF PATHOLOGICAL STATE BY ANTAGONIZING BRADYKININ RECEPTOR INCLUDING TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA (HAE) ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,648,333

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany38 39 581.9Nov 24, 1988
Germany39 16 291.5May 19, 1989
Germany39 26 225.8Jun 03, 1989
Germany39 26 822.5Aug 14, 1989

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Accenture
McKinsey
Chinese Patent Office
Federal Trade Commission
Healthtrust
Daiichi Sankyo
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.